A systematic review of health state utility values for osteoporosis-related conditions

Osteoporosis International

Volumn 13, Issue 10, 2002, Pages 768-776

  Brazier, J E ^a,d   Green, C ^b   Kanis, J A ^c  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b MEDTAP International   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Health state utility values; Osteoporosis

Indexed keywords

ARTICLE; BIBLIOGRAPHIC DATABASE; ECONOMIC EVALUATION; EXPERT SYSTEM; FRAGILITY FRACTURE; HEALTH STATE UTILITY VALUES; HIP FRACTURE; NURSING HOME; OSTEOPOROSIS; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; UNITED KINGDOM; VERTEBRA FRACTURE; VISUAL ANALOG SCALE; WRIST FRACTURE;

AGED; COST OF ILLNESS; FRACTURES, BONE; HEALTH STATUS; HUMANS; MIDDLE AGED; MODELS, ECONOMIC; OSTEOPOROSIS; QUALITY-ADJUSTED LIFE YEARS;

EID: 0036820818     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001980200107     Document Type: Article

References (32)

1. Department of Health and the Association of the British Pharmaceutical Industry Guidelines for the economic evaluation of pharmaceuticals [Press release]. London: Department of Health, 1994.
2. Commonwealth Department of Health, Housing and Community Service Guidelines for the pharmaceutical industry on the submission to the pharmaceutical benefits advisory committee. Canberra: Australian Government Publishing Service, 1992.
3. Ministry of Health (Ontario) Ontario guidelines for the economic evaluation of pharmaceutical products. Toronto: Ministry of Health, 1994.
4. Drummond MF, O'Brien B, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes, 2nd edn, Oxford: Oxford Medical Publications, 1997.
5. Weinstein MC, Statson WB. Foundations of cost-effectiveness analysis for health and medical practices. N Eng J Medicine 1977;296:716.
6. Murray CJL. Rethinking DALY's. In: Murray CJL, Lopez AD, eds. The global burden of disease. Geneva, WHO 1996:1-89.
7. Sculpher M, Torgerson D, Goeree R, O'Brien B. A critical structured review of economic evaluations of interventions for the prevention and treatment of osteoporosis. Discussion Paper 169. York: The University of York Centre for Health Economics, 1999.
8. Torgerson DJ, Reid DM. The economics of osteoporosis and its prevention. A review. PharmacoEconomics 1997;11(2):126-38.
9. Torrance GW. Measurement of health state utilities for economic appraisal: a review. J Health Econo 1986;5:1-30.
10. Jachuk SJ, Brierley H, Jachuk S, Wilcox PM. The effect of hypertensive drugs on the quality of life. J R Col Gen Pract 1982;32(235):103-5.
11. Dolan P. The measurement of health related quality of life for use in resource allocation in health care. In Culyer AJ, Newhouse JP, eds. Handbook of health economics, vol. 1, Elsevier Science: Amsterdam 2000.
12. Gabriel SE, Kneeland TS, Melton LJ, 3rd, Moncur MM, Ettinger B, Tosteson AN. Health-related quality of life in economic evaluations for osteoporosis: whose values should we use? Med Decis Making 1999;19:141-8.
13. Brooks RG. 'Euroqol: the current state of play', Health Policy 1996;37:53-72.
14. Fitzpatrick R, Zeibland S, Jenkinson C, Mowat, A. A comparison of the sensitivity to change of several health status measures in rheumatoid arthritis. J Rheumatol 1993;20:429-36.
15. Torrance GW, Furlong W, Feeny D, Boyle M. Multi-attribute preference functions. Health Utilities Index. PharmacoEconomics 1995;7:503-20.
16. Brazier J, Deverill M, Green C. A review of the use health status measures in economic evaluation. J Health Services Res Policy 1999;4(3):174-84.
17. Sackett DL, Torrance GW. The utility of different health states as perceived by the general public. J Chron Dis 1978;31:697-704.
18. Boyd N, Sutherland H, Heasand K, Trichler D, Cummings B. Whose values for decision analysis? Med Decis Making, 1990;10:58.
19. Lenert LA, Treadwell JR, Schwartz CE. Associations between health status measures and utilities: implications for policy. Med Care 1999;37:479-89.
20. Gold MR, Siegel JE, Russell LB, Weinstein MC Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996.
21. Dolan P, Torgeson D, Kumar Kalarlapudi TK. Health related quality of life of Colles' fracture patients. Osteoporos Int 1999;9:196-9.
22. Salkeld G, Cameron ID, Cumming RG et al. Quality of life related to fear of falling and hip fracture in older women: a time trade-off study. BMJ 2000;320:241-6.
23. Oleksik A, Lips P, Dawson A et al. Health related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fracture. J Bone Miner Res 2000;15:1384-92.
24. Brazier JE, Kohler B, Walters S. A Prospective study of the health related quality of life impact of hip fracture. Sheffield: ScHARR, University of Sheffield, 2000.
25. Kind P, Dolan P, Gudex C, Williams A. Variations in population health status: results from a UK national questionnaire survey. BMJ 1998;316:736-41.
26. National Osteoporosis Foundation. Osteoporosis: review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis. Osteoporos Int 1998;8:1-88.
27. Roberge R, Berthelot J-M, Cranswick K. Adjusting life expectancy to account for disability in the population: a comparison of three techniques. Social Indicators Res 1999;48:217-43.
28. Zethraeus N, Lindgren P, Johnell O et al. A computer model to analyse the cost-effectiveness of HRT - a revised version. Working paper Series in Economics and Finance, No. 368. Stockholm School of Economics, Sweden.
29. Briggs AH, Gray AM. Handling uncertainty when performing economic evaluation of health care interventions. Health Technol Assess 1999;3:2.
30. Tengs TO, Wallace A. One thousand health-related quality-of-life estimates. Med Care 2000;38:583-637.
31. Brazier JE, Harper R, Thomas K, Jones N, Underwood T. Deriving a preference based single index measure from the SF-36 J Clin Epidemiol 1998;51:1115-29.
32. Ioannidis G, Adachi JD, Guyatt GH. Development and validation of the mini-Osteoporosis Quality of Life Questionnaire in osteoporotic women with back pain due to vertebral fractures. Osteoporos Int 1999;3:207-13.